CSA Group Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables ISO 10993-16:2017

Description
ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.
Description
ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.

Suppliers

Company
Product
Description
Supplier Links
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables - ISO 10993-16:2017 - CSA Group
Toronto, Ontario, Canada
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables
ISO 10993-16:2017
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables ISO 10993-16:2017
ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.

ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.

Supplier's Site

Technical Specifications

  CSA Group
Product Category Standards and Technical Documents
Product Number ISO 10993-16:2017
Product Name Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables
Unlock Full Specs
to access all available technical data

Similar Products